Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | GGTI-2418 |
| Synonyms | |
| Therapy Description |
GGTI-2418 is a selective inhibitor of GGTase I, leading to inhibition of protein geranylgeranylation, cell cycle arrest, and potentially inhibition of tumor growth (PMID: 19204084). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| GGTI-2418 | PTX-100 | GGTI-2418 is a selective inhibitor of GGTase I, leading to inhibition of protein geranylgeranylation, cell cycle arrest, and potentially inhibition of tumor growth (PMID: 19204084). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT03900442 | Phase I | GGTI-2418 | Phase 1 Study of PTX-100 in Patients With Advanced Malignancies | Completed | AUS | 0 |
| NCT06854653 | Phase II | GGTI-2418 | A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL | Recruiting | USA | ITA | FRA | AUS | 0 |